Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
Sponsor: Encore Clinical
Listed as NCT01817192, this NA trial focuses on Non-Small Cell Lung Cancer and remains ongoing. Sponsored by Encore Clinical, it has been updated 29 times since 2020, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
29 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting NA
-
May 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Apr 2025 — May 2025 [monthly]
Active Not Recruiting NA
-
Mar 2025 — Apr 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Mar 2025 [monthly]
Recruiting NA
▶ Show 24 earlier versions
-
Aug 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Recruiting NA
-
Aug 2023 — Jan 2024 [monthly]
Recruiting NA
-
Mar 2023 — Aug 2023 [monthly]
Recruiting NA
-
Jan 2023 — Mar 2023 [monthly]
Recruiting NA
-
Dec 2022 — Jan 2023 [monthly]
Recruiting NA
-
Nov 2022 — Dec 2022 [monthly]
Recruiting NA
-
Sep 2022 — Nov 2022 [monthly]
Recruiting NA
-
Jun 2022 — Sep 2022 [monthly]
Recruiting NA
-
Feb 2022 — Jun 2022 [monthly]
Recruiting NA
-
Jan 2022 — Feb 2022 [monthly]
Recruiting NA
-
Dec 2021 — Jan 2022 [monthly]
Recruiting NA
-
Nov 2021 — Dec 2021 [monthly]
Recruiting NA
-
Oct 2021 — Nov 2021 [monthly]
Recruiting NA
-
Sep 2021 — Oct 2021 [monthly]
Recruiting NA
-
Apr 2021 — Sep 2021 [monthly]
Recruiting NA
-
Mar 2021 — Apr 2021 [monthly]
Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
-
Aug 2020 — Oct 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Not Yet Recruiting NA
Status: Active Not Recruiting → Not Yet Recruiting
-
Jun 2018 — Jul 2020 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Encore Clinical
- Razor Genomics
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Angers, France , Asheville, United States , Bayonne, France , Besançon, France , Bordeaux, France , Boulogne, France , Clamart, France , Cologne, Germany , Créteil, France , Fort Meyers, United States and 35 more locations